Haoqinbio startup was founded in 2021 in BioLabs at the Lundquist Institute of Harbor-UCLA Medical Center.

We focus on nucleic acid amplification technology. Initially, we provided nucleic acid testing kits, followed by nucleic acid sequencing library preparation kits.

Now we are introducing new multiplex immunofluorescence assays. With our proven technology, we have removed the limitation on the number of protein targets that can be detected in multiplex immunofluorescence experiments.